Page last updated: 2024-09-03

pak 104p and etoposide

pak 104p has been researched along with etoposide in 1 studies

Compound Research Comparison

Studies
(pak 104p)
Trials
(pak 104p)
Recent Studies (post-2010)
(pak 104p)
Studies
(etoposide)
Trials
(etoposide)
Recent Studies (post-2010) (etoposide)
160018,3063,6934,900

Protein Interaction Comparison

ProteinTaxonomypak 104p (IC50)etoposide (IC50)
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]Homo sapiens (human)1.153
nuclear receptor coactivator 3 isoform aHomo sapiens (human)1.4284
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)3.187
Caspase-3Homo sapiens (human)1
DNA topoisomerase 2-betaHomo sapiens (human)0.4299
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)4.18

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aikou, T; Akiyama, S; Furukawa, T; Ikeda, R; Kitazono, M; Nagayama, S; Okumura, H; Seto, K; Sumizawa, T1

Other Studies

1 other study(ies) available for pak 104p and etoposide

ArticleYear
Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells.
    International journal of cancer, 2001, Jan-01, Volume: 91, Issue:1

    Topics: Alkaloids; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Butyrates; Carcinoma; Cell Nucleus; Colonic Neoplasms; Coloring Agents; Cyclic P-Oxides; Cytoplasm; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Microscopy, Fluorescence; Neoplasm Proteins; Nicotinic Acids; RNA, Catalytic; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles

2001